Literature DB >> 25855150

Optimizing the lipidomics workflow for clinical studies--practical considerations.

Tuulia Hyötyläinen1, Matej Orešič.   

Abstract

Lipidomics is increasingly being used in clinical research, offering new opportunities for disease prediction and detection. One of the key challenges of clinical applications of lipidomics is the high sensitivity of measured lipid levels to many analytical, physiological, and environmental factors, which therefore must be taken into account when designing the studies. Here we critically discuss the complete clinical lipidomics workflow, including selection of the subjects, the sample type, the sample preprocessing conditions, and the analytical method and methods for data processing. We also review the lipidomics applications which investigate the confounding factors such as age, gender, fasting time, and handling procedures for measuring blood lipid metabolites.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855150     DOI: 10.1007/s00216-015-8633-2

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  16 in total

Review 1.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

Review 2.  Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences.

Authors:  Kui Yang; Xianlin Han
Journal:  Trends Biochem Sci       Date:  2016-09-20       Impact factor: 13.807

3.  Metabolic View on Human Healthspan: A Lipidome-Wide Association Study.

Authors:  Justin Carrard; Hector Gallart-Ayala; Denis Infanger; Tony Teav; Jonathan Wagner; Raphael Knaier; Flora Colledge; Lukas Streese; Karsten Königstein; Timo Hinrichs; Henner Hanssen; Julijana Ivanisevic; Arno Schmidt-Trucksäss
Journal:  Metabolites       Date:  2021-04-30

4.  Plasma lipidome variation during the second half of the human lifespan is associated with age and sex but minimally with BMI.

Authors:  Matthew Wai Kin Wong; Nady Braidy; Russell Pickford; Fatemeh Vafaee; John Crawford; Julia Muenchhoff; Peter Schofield; John Attia; Henry Brodaty; Perminder Sachdev; Anne Poljak
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

5.  Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.

Authors:  John A Bowden; Alan Heckert; Candice Z Ulmer; Christina M Jones; Jeremy P Koelmel; Laila Abdullah; Linda Ahonen; Yazen Alnouti; Aaron M Armando; John M Asara; Takeshi Bamba; John R Barr; Jonas Bergquist; Christoph H Borchers; Joost Brandsma; Susanne B Breitkopf; Tomas Cajka; Amaury Cazenave-Gassiot; Antonio Checa; Michelle A Cinel; Romain A Colas; Serge Cremers; Edward A Dennis; James E Evans; Alexander Fauland; Oliver Fiehn; Michael S Gardner; Timothy J Garrett; Katherine H Gotlinger; Jun Han; Yingying Huang; Aveline Huipeng Neo; Tuulia Hyötyläinen; Yoshihiro Izumi; Hongfeng Jiang; Houli Jiang; Jiang Jiang; Maureen Kachman; Reiko Kiyonami; Kristaps Klavins; Christian Klose; Harald C Köfeler; Johan Kolmert; Therese Koal; Grielof Koster; Zsuzsanna Kuklenyik; Irwin J Kurland; Michael Leadley; Karen Lin; Krishna Rao Maddipati; Danielle McDougall; Peter J Meikle; Natalie A Mellett; Cian Monnin; M Arthur Moseley; Renu Nandakumar; Matej Oresic; Rainey Patterson; David Peake; Jason S Pierce; Martin Post; Anthony D Postle; Rebecca Pugh; Yunping Qiu; Oswald Quehenberger; Parsram Ramrup; Jon Rees; Barbara Rembiesa; Denis Reynaud; Mary R Roth; Susanne Sales; Kai Schuhmann; Michal Laniado Schwartzman; Charles N Serhan; Andrej Shevchenko; Stephen E Somerville; Lisa St John-Williams; Michal A Surma; Hiroaki Takeda; Rhishikesh Thakare; J Will Thompson; Federico Torta; Alexander Triebl; Martin Trötzmüller; S J Kumari Ubhayasekera; Dajana Vuckovic; Jacquelyn M Weir; Ruth Welti; Markus R Wenk; Craig E Wheelock; Libin Yao; Min Yuan; Xueqing Heather Zhao; Senlin Zhou
Journal:  J Lipid Res       Date:  2017-10-06       Impact factor: 5.922

6.  Ultrahigh-Resolution Mass Spectrometry-Based Platform for Plasma Metabolomics Applied to Type 2 Diabetes Research.

Authors:  Yanlong Zhu; Benjamin Wancewicz; Michael Schaid; Timothy N Tiambeng; Kent Wenger; Yutong Jin; Heino Heyman; Christopher J Thompson; Aiko Barsch; Elizabeth D Cox; Dawn B Davis; Allan R Brasier; Michelle E Kimple; Ying Ge
Journal:  J Proteome Res       Date:  2020-10-15       Impact factor: 4.466

7.  Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome.

Authors:  Susanne Sales; Juergen Graessler; Sara Ciucci; Rania Al-Atrib; Terhi Vihervaara; Kai Schuhmann; Dimple Kauhanen; Marko Sysi-Aho; Stefan R Bornstein; Marc Bickle; Carlo V Cannistraci; Kim Ekroos; Andrej Shevchenko
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

8.  Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers.

Authors:  Joost Brandsma; Victoria M Goss; Xian Yang; Per S Bakke; Massimo Caruso; Pascal Chanez; Sven-Erik Dahlén; Stephen J Fowler; Ildiko Horvath; Norbert Krug; Paolo Montuschi; Marek Sanak; Thomas Sandström; Dominick E Shaw; Kian Fan Chung; Florian Singer; Louise J Fleming; Ana R Sousa; Ioannis Pandis; Aruna T Bansal; Peter J Sterk; Ratko Djukanović; Anthony D Postle
Journal:  Metabolomics       Date:  2018-09-17       Impact factor: 4.290

9.  Plasma lipid species at type 1 diabetes onset predict residual beta-cell function after 6 months.

Authors:  Anne Julie Overgaard; Jacquelyn M Weir; Kaushala Jayawardana; Henrik Bindesbøl Mortensen; Flemming Pociot; Peter J Meikle
Journal:  Metabolomics       Date:  2018-12-04       Impact factor: 4.290

10.  Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes - Type 1 Diabetes Prediction and Prevention Study (DIPP).

Authors:  Santosh Lamichhane; Linda Ahonen; Thomas Sparholt Dyrlund; Esko Kemppainen; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Oresic
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.